INSIDER TRADING

Bruce Polsky, a director at Atea Pharmaceuticals, Inc., sells $168,095 of stock

By Insider Stock Trader Newsroom, Insider Stock Trader: Alerts app2 min readInsider Stock Trader
Bruce Polsky, a director at Atea Pharmaceuticals, Inc., sells $168,095 of stock

After the sale, the filing lists 158,580 shares held. By the Insider Stock Trader: Alerts app. Information only, not investment advice.

A director at Atea Pharmaceuticals, Inc., Bruce Polsky, sold 41,226 shares of the company's stock on the open market between Nov 16 and Nov 18. The sale, at an average of $4.08 a share, comes to $168,095.

The Form 4 does not tick the Rule 10b5-1 box: the sale is not reported as part of a pre-arranged trading plan. The trade was reported within two business days, as Section 16 requires.

After the trade, the filing lists 158,580 shares held. No other open-market sale at Atea Pharmaceuticals, Inc. was reported in the previous 90 days.

Figures come from the Form 4 filed with the SEC; the table lists the open-market rows this article covers.

The sale
CompanyAtea Pharmaceuticals, Inc. (AVIR)
InsiderBruce Polsky
RoleDirector
TransactionOpen-market sale (code S)
Shares41,226
Average price$4.08
Value$168,095
Trade datesNov 16 to Nov 18, 2026
Filed with the SECNov 18, 2026, 8:59 PM ET
Shares held after158,580
OwnershipDirect
Rule 10b5-1 planNot marked in the filing

See the detailed report on this AVIR sale

View the Form 4 on SEC.gov

See the latest cluster buys and sells · Browse the insider trading newsroom

Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.